Search

You searched for "acuity"

1262 results found

Shedding light on Wolfram syndrome: The unveiling of a delayed diagnosis

12 August 2025 | | EYE - Neuro-ophthalmology
Wolfram syndrome 1 (WS1) was first described by Wolfram and Wagener in 1938 and it’s a rare neurodegenerative, progressive disorder, also known as DIDMOAD (diabetes insipidus, diabetes mellitus, optic atrophy, and deafness) [1]. We present an atypical case of WS...

Sclerochoroidal calcification masquerading as ocular malignancy

5 April 2022 | | EYE - Vitreo-Retinal, EYE - General
Case 1 A 68-year-old Caucasian gentleman was urgently referred to eye casualty by his optometrist after seeing an unusual incidental finding of protruding lesions from the retina, suspecting choroidal melanoma. He was asymptomatic and this was his first eye test...

“I can’t see nothing out of that eye, you ....!”

1 February 2015 | | EYE - Imaging, EYE - Orbit, EYE - General
This is exactly the call you don’t want to receive at 11 at night. The A&E colleague phoned to inform me about a young man who was kicked several times in the face and could not see out of one...

Forward-tilt technique for intraocular pressure measurement in upgaze

5 June 2020 | | EYE - Glaucoma, EYE - General
The authors suggest a technique to improve the accuracy of measuring IOP in upgaze using Goldmann applanation tonometry. Graves’ ophthalmopathy, also known as thyroid eye disease, is an autoimmune inflammatory condition affecting the orbit and periorbital tissues [1]. It was...

My ophthalmic elective: Lerdsin Hospital, Thailand

2 June 2021 | | EYE - General
My decision to undertake elective in Thailand was made to help broaden my horizons on ophthalmic conditions and practices. Additionally, I hoped to improve my Thai medical vocabulary to communicate with Thai patients fluently. As I got an opportunity to...

My Top Five: Promising gene therapies for ocular conditions

4 December 2024 | | EYE - Vitreo-Retinal
Gene therapy, a pivotal advancement in modern medicine, particularly shines in ophthalmology. By targeting defective genes with engineered vectors, this approach promises significant strides in treating inherited retinal diseases. This article reviews the top five gene therapies in late-stage trials,...

My Top Five: Promising gene therapies for ocular conditions

4 December 2024 | | EYE - Vitreo-Retinal
Gene therapy, a pivotal advancement in modern medicine, particularly shines in ophthalmology. By targeting defective genes with engineered vectors, this approach promises significant strides in treating inherited retinal diseases. This article reviews the top five gene therapies in late-stage trials,...

Paediatric ophthalmology training in Africa through the Juba-Bournemouth VISION 2020 LINK

1 December 2018 | | EYE - Paediatrics, EYE - Strabismus, EYE - General
One of the aims of the College of Ophthalmology of Eastern, Central and Southern Africa (COECSA) is to provide specialist ophthalmic training for practising ophthalmologists from its 11 member countries. A number of initiatives are enabling more ophthalmologists to undertake...

Surgical treatment of high myopia

1 June 2016 | | EYE - Cataract, EYE - Refractive
Although several excellent modalities are available for correcting high myopia, the surgical treatment of this condition remains one of the biggest challenges for refractive surgeons; this group of patients is often very dependent on contact lenses. If these patients become...

Management of retinal diseases: highlights from the AAO 2019 Retina Subspecialty Day Meeting

2 December 2019 | | EYE - Vitreo-Retinal, EYE - General
The author highlights current debate, opinion and late breaking developments in the management of retinal diseases. The American Academy of Ophthalmology’s 2019 Retina Subspecialty Day Meeting was held on 11-12 October, 2019 in San Francisco, USA. Established and emerging innovative...

Broadening of treatment options for potentially blinding retinal conditions

2 August 2022 | | EYE - General
Rod McNeil provides an update on a promising bispecific antibody recently approved for treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DMO) and considers emerging developments in biosimilars to established anti-vascular endothelial growth factor (anti-VEGF) therapies, including...

Birmingham welcomes new ophthalmology hospital

25 January 2024 | CHEC, community services, healthcare, infrastructure, hospital
CHEC’s new Kings Norton site set to reduce NHS waiting times and increase patient choice.